Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-24 @ 11:56 PM
NCT ID:
NCT04564651
Eligibility Criteria:
Inclusion Criteria:
* 18-60 years old;
* Patients with compensated cirrhosis conformed to the (ACLF) diagnostic criteria of chronic and acute liver failure defined by the European Association of Hepatology (EASL-CLIF), and met the ACLF-2 and 3 grades.
ADP inhibition rate ≥ 70%.
Exclusion Criteria:
* Patients with severe platelet allergy in the past;
* Coma caused by cerebral hemorrhage or primary diseases of the nervous system;
* Those who have taken anti-platelet drugs or anticoagulants within four weeks;
* Rupture and bleeding of EVB occurred within 1 week.
* Those who received platelet transfusion within 1 week;
* Patients with liver cancer or other malignant tumors;
* Pregnant and lactating women;
* Complicated with other serious chronic diseases;
* Not signing the informed consent form;
* Other researchers do not consider it appropriate to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
60 Years
Study:
NCT04564651
Study Brief:
Protocol Section:
NCT04564651